pharma topic page on Anadi Algo News

Monday, June 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
AnadiAlgoNews
सट्टा नहीं, सिस्टम
Topic Landing|80 matching stories

pharma News, Sentiment & Trading Insights

AI-analyzed coverage for the pharma theme, including latest market stories, signals and related articles.

What Traders Do Next

pharma is more useful with a process around it.

Use these pages to understand the story first. Execution usually comes later, after the idea is filtered, tested, and sized correctly.

Translate It into Rules

See how a market theme can turn into a structured workflow instead of impulse.

Check the Setup

Use a validation step before any trade decision starts feeling obvious.

Read the Main Algo Guide

Start broad if you want to understand the workflow before you optimize the setup.

This is here if you want to go deeper, not as a push.Explore Anadi
Top Story|et_companiesabout 22 hours ago

14 Indians aboard MSV Virat 1 successfully rescued, crew heads to Mumbai

The provided sector context is for pharma, which is unrelated to this maritime incident. This news has no relevance to the pharma sector's current dynamics.

Neutral80%
0

Impact Score

No trade setup is applicable for the pharma sector based on this news. Traders should adhere to their existing strategies for pharma stocks.
et_economy1 day ago

Electronics, pharma and engineering goods lead India's FTA dividend as export engine shifts gears

The pharma sector is currently influenced by rupee weakness and defensive buying, alongside patent wins and tariff risks. This news adds a positive export-driven growth dimension.

buy
Bullish+7590%
5 facts
Consider a long bias on fundamentally strong Indian pharma stocks with a focus on export markets, maintaining strict risk discipline given regulatory and pricing pressures.
et_companies1 day ago

India known as nation with world's largest healthcare programme: PM Modi

Government focus on affordable healthcare creates a large domestic market. Positive for pharma and hospital chains.

Bullish+6085%
5 facts
Long-term bullish bias for healthcare and pharma. Focus on companies with strong domestic presence.
et_companies1 day ago

Maharashtra FDA bars hospitals from forcing patients to buy medicines in-house

Regulatory scrutiny on healthcare practices is increasing, impacting revenue models. This directive highlights a shift towards greater patient autonomy and transparency in drug procurement.

sell
Neutral-6090%
5 factsAPOLLOHOSPMAXHEALTHNARAYANAHRU
Consider a bearish bias for hospital stocks with high pharmacy revenue contribution, with risk managed by monitoring regulatory enforcement and company-specific disclosures.

Latest pharma Topic Coverage

livemint_markets1 day ago+65

Small-cap stock under ₹50 to be in focus on Monday. Details here

buy5 factsPharmaceuticals
Maintain a bullish bias on Sudarshan Pharma, looking for price appreciation; manage risk with appropriate stop-loss orders.
et_companies2 days ago+60

Sebi to issue guidelines on responsible use of AI in capital markets, chief Pandey says

buy5 factsTCSLTIMInformation TechnologyFinancial Services
Maintain a watchful stance on pharma stocks, focusing on companies with strong R&D pipelines and favorable regulatory outcomes, while being mindful of broader market sentiment driven by financial sector developments.
et_companies2 days ago+20

Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriers

5 factspharma
Neutral to slightly cautious bias for specialty pharma; watch for government intervention on drug pricing or local manufacturing mandates.
et_markets2 days ago+60

Concurrent Gainers: 11 stocks gain for 5 straight sessions, rally up to 20%

5 facts
For pharma, look for stocks with strong technical momentum combined with positive news flow (e.g., USFDA approvals, new product launches) for potential long positions, maintaining strict risk management.
et_markets2 days ago+10

Uday Kotak questions SpaceX valuation, says only time will tell if we're in ‘mega bubble'

5 factspharma
Neutral, but with a cautious undertone for high-valuation Indian growth stocks.
et_economy2 days ago+75

India's FTAs set stage for $1 trillion export target: Report

buy5 factsElectronicsPharmaceuticals
Maintain a bullish bias on export-focused pharma stocks, but closely monitor USFDA approvals and any potential pricing pressures in key markets.
et_economy3 days ago+40

Call to extend duty cuts on critical inputs soon

buy5 factsSUNPHARMATATASTEELJSWSTEELpharma
Positive bias for pharma and steel stocks, pending official duty cut announcements.
livemint_companies3 days ago+15

Advent International Is Said Near Close of $26 Billion Fund

4 factspharma
Neutral, but watch for potential future PE investments in Indian companies.
et_markets3 days ago+60

Revised common application form for FPIs notified

5 factspharma
Positive for broad market indices (Nifty, Sensex) and government bonds; consider long positions in quality large-cap stocks.
et_markets3 days ago+30

Sebi to review delisting framework to ease exits

5 factspharma
Neutral for broad market; specific opportunities may arise for companies that become delisting targets.
et_markets3 days ago+50

Sebi weighs introducing long-term futures and options contracts: Tuhin Kanta Pandey

5 factspharma
Bullish for exchanges and brokerage houses; consider long positions in companies benefiting from increased market activity.
et_companies3 days ago+65

Anupam Rasayan becomes world's first to make ETFA using flow chemistry

buy5 factsANURASSpecialty ChemicalsPharmaceuticals
Maintain a bullish bias on ANURAS for long-term growth, but be mindful of the stock's current valuation as the market has likely absorbed this news.
et_economy3 days ago+40

Chhattisgarh attracts Rs 9,500 crore in fresh investment MoUs

5 factsPharmaceuticalsRenewable Energy
Maintain a bullish bias on established pharma players with strong balance sheets, looking for consolidation or expansion news in states offering industrial incentives. Risk discipline is crucial, especially given the sector's sensitivity to regulatory changes.
et_markets3 days ago-60

BlackRock says oil, FX risks loom over India's bond inflow push

5 factsFinancial ServicesOil & Gas
Maintain a 'buy on dips' strategy for fundamentally strong pharma stocks, focusing on companies with robust pipelines and USFDA compliance, but be disciplined with stop-losses.
et_markets3 days ago-60

'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautious

sell5 factsitpharma
Bearish bias for IT and Metals; Bullish bias for Pharma and Healthcare.
et_markets3 days ago

Bitcoin trades near $63,600 as sentiment nears 2022 bottom levels. Here is what experts say

5 factspharma
No direct trade setup for Indian equities.
livemint_markets3 days ago+50

Hexagon Nutrition share price hits 5% upper circuit after strong listing. Should you buy, sell or hold the stock?

buy5 factspharma
Neutral to bullish for Hexagon Nutrition; watch for price stability after initial volatility.
livemint_companies3 days ago+31.9

Voice AI startup Equal raises $30 million from Prosus Ventures, Tomales Bay

5 factsInformation TechnologyVenture Capital
Maintain a bullish bias on Indian IT stocks with strong AI and digital service offerings, looking for dips as buying opportunities.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
livemint_companies3 days ago+46.9

Used-car platform Spinny begins work on IPO, eyes up to $300 million raise

5 factsAutomotiveE-commerce
For pharma, focus on companies with strong product pipelines and favorable regulatory outcomes. Maintain a bullish bias on select pharma stocks, especially those benefiting from rupee weakness or defensive buying.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
et_companies3 days ago+52.2

India raises price cap on cancer drugs to tackle shortage

hold5 factsSUNPHARMAPharmaceuticals
Maintain a bullish bias on Indian pharma stocks with strong oncology segments, focusing on companies that produce these specific drugs, with disciplined risk management.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
et_markets3 days ago+42.6

BSE CEO Sundararaman Ramamurthy on building trust, fighting deepfakes, and why yuva shakti & nari shakti are future of Indian market

hold5 factsBSEFinancial ServicesExchanges & Brokerage
Maintain a bullish bias on exchange stocks like BSE, looking for dips as buying opportunities, given the long-term growth drivers.|Quick check: BSE bearish bias (-1.0% 1d), SUNPHARMA neutral (oversold).
et_markets3 days ago+45.4

US-based Tryfacta files draft papers for $100-150 million GIFT City IPO

hold5 factsNSEFinancial ServicesCapital Markets
Maintain a bullish bias on financial infrastructure and exchange-related stocks, as this event could catalyze further foreign listings and capital inflows into India.|Quick check: NSE neutral, SUNPHARMA neutral (oversold).
et_markets3 days ago+16.9

Never sell because you're bored': PPFAS CIO Rajeev Thakkar's 6-point guide on when to exit an investment

5 factsFinancial ServicesAsset Management
For pharma stocks, maintain a 'hold' bias for quality names, but be prepared to trim positions if extreme overvaluation or structural disruption (e.g., major regulatory changes or patent expirations) becomes evident, with strict stop-losses.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
livemint_companies3 days ago-55.2

Why US drug regulator has taken action against drugs imported from Dabur India

hold5 factsDABURPharmaceuticalsFMCG
Maintain a cautious stance on Indian pharma stocks with significant US export exposure; prioritize companies with strong compliance records.|Quick check: DABUR bearish bias (-0.8% 1d), SUNPHARMA neutral (oversold).
livemint_markets3 days ago-47.8

Dabur shares in focus after USFDA issues import alert for drugs made at Silvassa plant. Check details

hold5 factsDABURPharmaceuticalsFMCG
Maintain a cautious stance on Dabur India (DABUR) due to regulatory uncertainty; consider short-term bearish positions or avoiding fresh longs until clarity emerges, with strict stop-losses.|Quick check: DABUR bearish bias (-0.8% 1d), SUNPHARMA neutral (oversold).
livemint_markets3 days ago+68.8

Rajesh Palviya of Axis Sec suggests Allied Blenders, Torrent Pharma, Zee Ent shares to buy today - 12 June

buy5 factsALLIEDBLTORNTPHARMZEELPharmaceuticalsMedia & Entertainment
For pharma, look for confirmation of buying interest in TORNTPHARM. For ALLIEDBL and ZEEL, consider short-term long positions with strict stop-losses, given these are analyst-driven calls.|Quick check: ALLIEDBL neutral, TORNTPHARM bullish bias (+3.0% 1d).
et_markets3 days ago+62

Why is market rising today? Sensex zooms 1,000 points, Nifty above 23,400. 4 key factors powering the rally

hold5 factsOil & GasAviation
For pharma, maintain a 'buy on dips' strategy, focusing on companies with strong product pipelines and regulatory approvals, as the broader market sentiment improves.|Quick check: NIFTY neutral (-7.2% 1d), SENSEX neutral.
et_markets3 days ago-55.2

Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s why

hold5 factsDABURPharmaceuticalsFMCG
Maintain a cautious bias on pharma stocks with significant US export exposure; prioritize companies with strong compliance records.|Quick check: DABUR bearish bias (-0.8% 1d), SUNPHARMA neutral (oversold).
et_markets3 days ago+0.7

Hexagon Nutrition shares set for market debut. Check GMP ahead of listing

sell5 factsNutritionPharmaceuticals
For new listings in this sector, look for companies with strong growth prospects and clear competitive advantages, but exercise caution on debut if GMPs are modest.|Quick check: TATASTEEL bearish bias (oversold), HINDALCO bearish bias (oversold).
et_markets3 days ago+46.9

Horizon Reclaim IPO opens for subscription today. Check GMP, price band and other details

hold5 factsChemicalsManufacturing
For IPOs with strong GMP, consider applying for listing gains, but always assess the company's fundamentals and sector outlook.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
et_companies3 days ago+33.9

UK approves Novo weight-loss pill to edge open European market

hold5 factsLUPINpharma
Positive bias for Indian pharma companies with strong R&D and global market access; look for companies with relevant therapeutic focus.|Quick check: LUPIN bullish bias (+1.1% 1d), SUNPHARMA neutral (oversold).
et_markets3 days ago+9.4

GenXAI Analytics shares set for listing. Here's what GMP suggests ahead of debut

5 factspharma
Neutral to cautious bias for GenXAI Analytics post-listing; avoid aggressive buying on debut unless strong fundamentals emerge.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
livemint_markets3 days ago+44.6

Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 12 June 2026

buy5 factsTORNTPHARMKOTAKBANKGRASIMbankingpharma
Bullish bias for the recommended stocks; consider long positions with defined stop-losses.|Quick check: TORNTPHARM bullish bias (+3.0% 1d), KOTAKBANK bullish bias (+1.4% 1d).
livemint_markets3 days ago+30

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 12 June 2026

hold5 factsJINDALPOLYSISAJANTPHARMbankingpharma
Bullish bias for the recommended stocks; consider long positions with defined stop-losses.|Quick check: JINDALPOLY neutral, SIS neutral.
et_economy4 days ago+31.9

Tieups with higher per capita income nations beneficial to all: Piyush Goyal

hold5 factsSUNPHARMApharma
Positive for export-oriented sectors. Look for companies with strong global presence.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
livemint_markets4 days ago+50

Multibagger Anupam Rasayan stock to be in focus on Friday on ETFA manufacturing milestone

sell5 factsANURASSpecialty ChemicalsPharmaceuticals
Maintain a bullish bias on ANURAS, looking for breakout opportunities. Consider long positions with a stop-loss below recent support levels.|Quick check: ANURAS bearish bias (oversold), SUNPHARMA neutral (oversold).
livemint_markets4 days ago-51.2

Oracle shares plunge 13% to 4-week low as AI-driven spending plans spook investors

sell5 factsTCSInformation Technology
Maintain a bearish bias on Indian large-cap IT stocks; consider short positions or reducing long exposure, with strict stop-losses if global tech spending sentiment improves unexpectedly.|Quick check: TCS bearish bias (-0.6% 1d), SUNPHARMA neutral (oversold).
et_companies4 days ago+31.9

Cancer drug prices raised 50% as NPPA acts on shortage concerns

5 factspharma
Look for Indian pharma companies with strong oncology or critical care portfolios; potential for margin improvement.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
et_companies4 days ago-55.2

US drug regulator issues import alert for drugs made at a Dabur India plant

hold5 factsDABURpharma
Negative bias for Dabur India (DABUR); potential for short-term price decline.|Quick check: DABUR bearish bias (-0.8% 1d), SUNPHARMA neutral (oversold).
et_markets4 days ago-35

Ahead of Market: 10 things that will decide stock market action on Friday

buy5 factsInformation TechnologyBanking
Consider long positions in fundamentally strong banking stocks on dips, with strict stop-losses, anticipating continued defensive buying.|Quick check: HDFCBANK neutral (-0.3% 1d), ICICIBANK bullish bias (+1.6% 1d).
et_markets4 days ago+30

Market Trading Guide: Allied Blenders among 2 stock recommendations for Friday

hold5 factsALLIEDBLJBCCHEMAlcoholic BeveragesPharmaceuticals
Maintain a cautious but opportunistic bias in banking stocks, looking for strong technical setups in fundamentally sound banks, with strict risk management.|Quick check: ALLIEDBL neutral, JBCCHEM neutral.
et_markets4 days ago+16.9

Quote of the day by Arnold Van Den Berg: "We believe that if a market is so overvalued that you can only find a few stocks to buy, you are probably better off not buying anything"

5 factsbroad_market
Maintain a selective 'buy on dips' strategy for quality stocks, or increase cash holdings for future opportunities.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+61.8

Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a month

buy5 factsHONASAAEGISCHEMGLANDpharmabroad_market
Focus on momentum trading for these specific stocks, looking for continuation patterns or consolidation breakouts.|Quick check: HONASA bullish bias (+1.0% 1d), AEGISCHEM neutral.
livemint_markets4 days ago+31.9

The good, the bad, and the ugly of the Indian stock market: How should investors navigate it?

5 facts
Look for accumulation opportunities in quality stocks across various sectors, focusing on companies with strong balance sheets and growth potential, with a long-term horizon.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+55.7

'Time to cherry pick again': Porinju Veliyath says small and midcaps have bottomed & Thomas Cook is his latest buy

hold5 factsTHOMASCOOKFinancial ServicesInformation Technology
Maintain a bullish bias on quality pharma stocks with strong R&D pipelines and favorable regulatory outlooks, focusing on companies with global market presence.|Quick check: THOMASCOOK neutral, SUNPHARMA neutral (oversold).
et_companies4 days ago+57.2

Fueling Demand: Inside India’s ethanol mobility revolution in reverse

hold5 factsMSILAutomobilesSugar
Long bias for sugar companies with ethanol capacity and auto OEMs actively developing flex-fuel models.|Quick check: MSIL neutral, SUNPHARMA neutral (oversold).
livemint_markets4 days ago+48.2

Indiabulls declares board meeting date to consider and approve ₹1000 crore preferential issue

hold5 factsINDIABULLSFinancial Services
For Indiabulls, a successful capital raise could lead to short-term positive momentum; consider a long position with a stop-loss below recent support levels.|Quick check: INDIABULLS neutral, SUNPHARMA neutral (oversold).
et_companies4 days ago+39.7

AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer

sell5 factsASTRAZENPharmaceuticals
Maintain a bullish bias on pharma companies with strong R&D pipelines and successful regulatory clearances, but always manage risk with stop-losses.|Quick check: ASTRAZEN bearish bias (oversold), SUNPHARMA neutral (oversold).
livemint_markets4 days ago+10.8

Vahh Chemicals share price lists at 17% premium over IPO price on BSE SME

hold5 factspharma
Bearish bias for Vahh Chemicals in the immediate term due to lower circuit hit; caution advised for new positions.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (-0.1% 1d).
et_markets4 days ago+53.1

Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplash

hold5 factsSUNPHARMALUPINPharmaceuticals
Consider long positions in established Indian pharma companies, with a focus on those with diversified product portfolios and strong balance sheets, maintaining strict stop-loss orders.|Quick check: SUNPHARMA neutral (oversold), LUPIN neutral (-0.8% 1d).
et_markets4 days ago+53.6

'India's AI index beat Mag-7 plus Nvidia': Hiren Ved says stop mourning FII exits and start investing smarter

5 factsInformation TechnologyFinancial Services
Maintain a bullish bias on Indian IT stocks with strong AI integration strategies; consider long positions in companies demonstrating clear AI-led innovation and efficiency gains, with a stop-loss below recent support levels.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (-0.1% 1d).
et_markets4 days ago+18.4

India's next decade: AI is an enabler, not a threat; investor expectations the real risk: Kailash Kulkarni

5 factsInformation TechnologyFinancial Services
For pharma, look for companies with strong R&D pipelines and diversified geographical revenue streams, considering defensive buying in times of market uncertainty.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (-0.1% 1d).
et_companies5 days ago+58.1

India's healthcare transformed in 12 years under PM Modi: Report

buy5 factsFORTISMAXHEALTHSTARHEALTHHealthcarePharmaceuticals
Maintain a bullish bias on healthcare stocks, focusing on companies with strong fundamentals and direct exposure to government initiatives, with a stop-loss below recent support levels.|Quick check: FORTIS bullish bias (+0.2% 1d), MAXHEALTH bullish bias (+0.5% 1d).
et_markets5 days ago+14.6

OpenAI expects to go public 'within the next year,' the Information reports

5 facts
Neutral to mildly positive for Indian IT; watch for AI-related project demand.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (-0.1% 1d).
et_markets5 days ago+29.5

Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday

hold5 factsADITYABSLpharmafinancial services
Bullish on Akums Drugs and ADITYABSL; consider long positions with defined stop-losses.|Quick check: ADITYABSL neutral, SUNPHARMA neutral (oversold).
livemint_companies5 days ago+7.1

Asics to spin off its Onitsuka Tiger sneaker business

4 facts
N/A, as the news is not related to the pharma sector.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (-0.1% 1d).
et_companies5 days ago+48.2

Hetero partners with Richter to develop, market Semaglutide injection globally

hold5 factsDRLSUNPHARMApharma
Positive bias for Indian pharma companies with strong R&D and global market access.|Quick check: DRL neutral, SUNPHARMA neutral (oversold).
et_economy5 days ago-45.5

Swiggy, Zomato, Uber asked to register gig workers by June 21: Report

hold5 factsZOMATOpharma
Negative bias for ZOMATO; potential for margin compression.|Quick check: ZOMATO neutral, SUNPHARMA neutral (oversold).
et_markets5 days ago+64

Zydus Lifesciences among 4 stocks that hit 52-week highs & rallied up to 17% in a month

buy5 factsZYDUSLIFEAPOLLOHOSPFEDERALBNKPharmaceuticalsHealthcare
Consider long positions in strong banking stocks showing positive momentum, maintaining strict stop-losses below recent support levels.|Quick check: ZYDUSLIFE bullish bias (overbought), APOLLOHOSP bullish bias (-0.5% 1d).
et_economy5 days ago+55.9

India's bond tax exemptions set to boost foreign debt inflows and global index inclusion bid

5 facts
Long Indian government bonds; anticipate yield compression due to increased demand.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (-0.1% 1d).
et_markets5 days ago+29.6

Physicswallah is ‘class’ apart, says DAM Capital after initiating with Buy rating. 3 reasons why

5 factsEducationTechnology
Maintain a watchlist of unlisted ed-tech companies and monitor news for IPO filings; consider early-stage investment opportunities if accessible, or look for indirect plays in allied sectors.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (-0.1% 1d).
livemint_companies5 days ago+18.4

Margin play: Why Supertails is doubling down on the lucrative pet healthcare market

5 factsAnimal HealthcareRetail
Consider a long-term bullish bias for Indian companies with established animal health divisions or those poised to enter the formal pet care market, focusing on companies with strong distribution networks.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (-0.9% 1d).
et_markets5 days ago+44.7

A new IPO frenzy: Why is Bharat making a beeline for bourses?

5 factsRetailConsumer Discretionary
Maintain a bullish bias on organized retail, focusing on companies with a clear strategy for 'Bharat' expansion, with a long-term investment horizon.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (-0.9% 1d).
et_markets5 days ago+58.9

Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw Irani

hold5 factsADANIENTDIXONCAMSFinancial ServicesConsumer Durables
For pharma, focus on domestic-oriented players or those with strong product pipelines and clear regulatory approvals, avoiding broad exposure to US-facing segments due to fund avoidance signals.|Quick check: ADANIENT neutral (+0.3% 1d), DIXON neutral (+2.1% 1d).
et_markets5 days ago+59.2

Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tablets

hold5 factsCONCORDBIOPharmaceuticals
Maintain a bullish bias on Indian pharma stocks with strong USFDA approval pipelines and established US market presence, focusing on companies demonstrating consistent regulatory compliance and product launches.|Quick check: CONCORDBIO bullish bias (+7.2% 1d), SUNPHARMA bearish bias (oversold).
et_markets5 days ago-41.6

Bitcoin trades 50% below all time high, below $62,000 as geopolitical uncertainty weighs on crypto sentiment

5 facts
Consider long positions in fundamentally strong pharma stocks with good product pipelines and USFDA approvals, maintaining strict stop-losses.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (-0.9% 1d).
et_companies5 days ago+39.6

Tata Consumer crosses Rs 20,000 crore revenue mark in FY26, net profit up 20%

sell5 factsTATACONSUMFast Moving Consumer Goods (FMCG)
Maintain a bullish bias on quality FMCG stocks, looking for entry points on minor pullbacks, with strict risk management.|Quick check: TATACONSUM bearish bias (oversold), SUNPHARMA bearish bias (oversold).
et_markets5 days ago+28.4

Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?

buy5 factsZYDUSLIFEDHANUKACYBERTECHPharmaceuticalsAgrochemicals
For these specific stocks, a 'wait and watch' approach is prudent post-buyback closure to assess the market's reaction to the reduced float and any subsequent price discovery.|Quick check: ZYDUSLIFE bullish bias (overbought), DHANUKA neutral.
livemint_markets5 days ago+23.2

CMR Green Technologies share price falls over 9% after strong listing. Should you buy, sell or hold the stock?

sell5 factsCMRGREENRecyclingMetals & Mining
For new listings in this sector, consider a cautious approach; wait for price discovery and consolidation before initiating long positions, with strict stop-losses.|Quick check: CMRGREEN neutral, SUNPHARMA bearish bias (oversold).
et_markets5 days ago+33.4

We are in Sankat Kaal, and in this Sagar Manthan, our job is to look for the next generation of winners: Saurabh Mukherjea

5 factsManufacturingExport-Oriented Industries
Consider long positions in fundamentally strong pharma exporters, focusing on companies with robust R&D and diversified product portfolios, with strict risk management.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (-0.9% 1d).
livemint_markets5 days ago+38.4

Reliance Industries share price jumps over 2% on partnering with Meta for India's first AI data centre

sell5 factsRELIANCETelecommunicationsTechnology
Maintain a 'buy on dips' strategy for fundamentally strong pharma stocks, with strict stop-losses below key support levels.|Quick check: RELIANCE bearish bias (oversold), SUNPHARMA bearish bias (oversold).
livemint_markets5 days ago+40.9

CMR Green Technologies share price makes a bumper debut, stock opens with 40% premium at ₹268 apiece on NSE

sell5 factsMetals & MiningRecycling
Look for opportunities in companies aligned with green technologies, recycling, or industrial manufacturing, with a bias towards strong fundamentals and clear growth prospects.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (-0.9% 1d).
et_markets5 days ago+40.6

Wipro's Rs 15,000 crore buyback opens tomorrow: Should retail investors tender shares?

sell5 factsWIPROInformation Technology
For Wipro, the immediate bias is bullish for shareholders participating in the buyback; for non-shareholders, monitor post-buyback price action for potential entry points based on improved fundamentals.|Quick check: WIPRO bearish bias (+0.1% 1d), SUNPHARMA bearish bias (oversold).
livemint_markets5 days ago+29.8

Bajaj Finserv to Union Bank - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment

hold5 factsBAJAJFINSVUNIONBANKDIVISLABFinancial ServicesBanking
For banking stocks like Union Bank, traders should look for confirmation of improved asset quality and credit growth, using the analyst's recommendation as a short-term directional bias with strict stop-losses.|Quick check: BAJAJFINSV bearish bias (oversold), UNIONBANK bullish bias (+1.9% 1d).
et_markets5 days ago+25.1

Stocks to buy in 2026 for long term: Bharti Airtel, IndiGo among 5 stocks that could give 10-30% return

hold5 factsBHARTIARTLINDIGOTelecommunicationsAviation
Maintain a bullish bias on the recommended stocks, but always use stop-losses and consider position sizing based on individual risk tolerance.|Quick check: BHARTIARTL bearish bias (oversold), INDIGO bullish bias (+3.6% 1d).
livemint_markets5 days ago-51.3

Stocks to watch: Ajanta Pharma, Bharti Airtel, IndiGo, NLC India, among key stocks in focus on 10 June

sell5 factsAJANTPHARMBHARTIARTLINDIGOPharmaceuticalsTelecommunications
Consider a cautious approach for pharma stocks; look for strong fundamentals and positive regulatory news to potentially outperform a weak market.|Quick check: AJANTPHARM neutral (+1.3% 1d), BHARTIARTL bearish bias (oversold).